23
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13278 |
Valecobulin hydrochloride
CKD-516 hydrochloride |
Microtubule Associated | Cytoskeletal Signaling |
Valecobulin hydrochloride (CKD-516 hydrochloride) 是 S516 的缬氨酸前体药和血管阻断剂。Valecobulin hydrochloride 对β-微管蛋白聚合有强效的抑制作用,对小鼠和人类的实体肿瘤具有显著的抗肿瘤活性。 | |||
T27841 |
Lobeglitazone Sulfate
CKD501 Sulfate,CKD501,CKD-501 Sulfate,CKD 501 Sulfate,CKD 501,CKD-501,Lobeglitazone Sulfate. trade name Duvie, Chong Kun Dang |
NOD | Immunology/Inflammation; NF-κB |
Lobeglitazone Sulfate(CKD-501 Sulfate) 是一种新型噻唑烷二酮,具有抗炎活性,抑制LPS诱导的NLRP3炎症小体活化和肝脏炎症,可用于研究 2 型糖尿病 (T2DM)。 | |||
T7551 |
Belotecan hydrochloride
CKD-602 |
Topoisomerase | DNA Damage/DNA Repair |
Belotecan hydrochloride (CKD-602) 是一种合成的水溶性喜树碱衍生物和拓扑异构酶 I 抑制剂,具有潜在的抗肿瘤活性。 | |||
T27033 |
CKD-712
CKD 712,CKD712 |
||
CKD-712 is a nuclear factor NF-kappa B inhibitor. CKD-712 suppressed MMP-9, but not MMP-2 and other NF-κB-regulated proteins involved in cancer metastasis such as VEGF. CKD-712 induced cell cycle arrest at G2M phase by suppressing cyclin A, cyclin B and C | |||
T36700 | CKD 602 | ||
Topoisomerase I inhibitor. Forms stable DNA-topoisomerase complexes during DNA replication and induces cell cycle arrest in the G2/M phase. Inhibits growth of a range of cancer cell lines in vitro, as well as of ovarian and leukemia tumors in vivo. | |||
T14976 | CKD-519 | Others | Others |
CKD-519 is a selective inhibitor of cholesteryl ester transfer protein (CETP). It inhibits CETP-mediated transfer of cholesteryl ester in human serum (IC50: 2.3 nM). | |||
T28945 |
Tenofovir disoproxil aspartate
CKD-390,CKD390,CKD 390 |
||
Tenofovir disoproxil aspartate, a nucleotide reverse transcriptase inhibitor, is used potentially for the treatment of HBV infection. | |||
T13278L |
Valecobulin
CKD-516 |
Others | Others |
Valecobulin is a potent β-tubulin polymerization inhibitor. Valecobulin is a valine prodrug of (S516) and an avascular disrupting compound. | |||
T19871 |
Beloranib
CKD-732,ZGN 440 |
||
Beloranib is a fumagillin anticancer drug. Beloranib belongs to an angiogenesis inhibitor. | |||
T69011 | Lobeglitazone | ||
Lobeglitazone, also known as CKD-501, is an antidiabetic drug in the thiazolidinedione class of drugs. As an agonist for both PPARα and PPARγ, it works as an insulin sensitizer by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. | |||
T8494 |
NS-3-008 hydrochloride
NS-3-008 HCl |
Others | Others |
NS-3-008 hydrochloride (NS-3-008 HCl) 是一种口服具有活性的G0s2转录抑制剂(IC50:2.25 μM)。它可用于慢性肾脏疾病的研究。 | |||
T16708 |
R-268712
|
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
R-268712 是选择性的 ALK5 抑制剂(IC50:2.5 nM)。 | |||
T71845 |
Lockdown
|
||
Lockdown is a reversible and non-competitive PPM1F inhibitor. Lockdown is selective for PPM1F, because this compound does not inhibit other protein phosphatases in vitro and does not induce additional phenotypes in PPM1F knockout cells. Lockdown acts in a dose-dependent, allosteric manner with high selectivity for PPM1F | |||
T30479 |
Bis-T-23
Bis T-23,Bis-T 23,AG1717 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Bis-T-23是一种肌动蛋白依赖性达纳敏低聚物的促进剂,是一种 HIV-I 整合酶抑制剂,是泰尔普斯丁衍生物。Bis-T-23可以促进肌动蛋白依赖性的dynamin 寡聚化。Bis-T-23可用于HIV 和慢性肾脏疾病(CKD)的研究。 | |||
T13604 |
CDDO-dhTFEA
|
Others; NF-κB; Nrf2 | Immunology/Inflammation; NF-κB; Others |
CDDO-dhTFEA 是合成的齐墩果烷三萜化合物,可有效激活Nrf2并抑制促炎转录因子NF-κB。 它可以恢复高血压 (MAP),提高 Nrf2 及其靶基因的表达,抑制 NF-κB 的活化和转化生长因子-β 途径,并减少慢性肾病 (CKD) 大鼠的肾小球硬化,间质纤维化和炎症。 | |||
T12823 | S516 | Microtubule Associated | Cytoskeletal Signaling |
S516 is an active CKD-516 metabolite and is a potent inhibitor of tubulin polymerization(IC50 of 4.29 μM), has marked antitumor activity. | |||
T62435 |
Belotecan
|
||
Belotecan (CKD-602 free base) 是一种 DNA topoisomerase I 抑制剂。Belotecan 能够阻滞细胞周期,并诱导细胞凋亡。Belotecan 是一种具有抗肿瘤作用的喜树碱衍生物,能够用于研究癌症。 | |||
T78513 |
Sodium zirconium cyclosilicate
|
Others | Others |
Sodium zirconium cyclosilicate 是一种新型口服、不吸收的无机微孔硅酸盐锆化合物,高选择性地作为阳离子交换剂,专门用于去除体内过量的K+。该化合物适用于慢性肾脏疾病(CKD)的研究。 | |||
T39410 |
Zevaquenabant
(S)-MRI-1867 |
||
Zevaquenabant ((S)-MRI-1867), a dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist, is orally bioavailable and peripherally restricted. It effectively mitigates obesity-induced chronic kidney disease (CKD). | |||
T73332 |
BI-685509
|
||
BI-685509 是一种口服有效的sGC 激活剂。BI-685509 可恢复环磷酸鸟苷 (cGMP) 并改善一氧化氮 (NO) 通路的功能。BI-685509 可用于慢性肾病 (CKD) 和糖尿病肾病 (DKD) 的研究。 | |||
T69294 | UK‑396082 | ||
UK-396082为一有效的TAFI抑制剂,能增进纤溶酶活性并促使ECM水平下降,适用于CKD研究。 | |||
T76947 | Ziltivekimab | ||
Ziltivekimab (COR-001) 是一种人源化抗IL-6单克隆抗体,具有降低血清CRP的效能,并展现出抗炎活性。该化合物在CKD相关的慢性全身性炎症及心血管疾病研究中有潜在应用。 | |||
T62589 |
TRPC5-IN-4
|
||
TRPC5-IN-4 是一种有效且安全的TRPC 抑制剂,对TRPC5和TRPC4的IC50分别为 14.07 nM 和 65 nM。TRPC5-IN-4 对肝、肾细胞成分无损伤。TRPC5-IN-4 可用于慢性肾脏病的研究 (CKD)。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8181 |
Poricoic acid A
Poricoic acid A(F),茯苓新酸 A |
Others | Others |
Poricoic acid A (Poricoic acid A(F)) 是提取于 Poria cocos 中,拥有抗肿瘤作用。它通过调节Gas6/AxlNFκB/Nrf2 轴提高AKI-to-CKD 的褪黑激素抑制。 | |||
T21977 |
p-Cresyl sulfate
|
Others | Others |
p-Cresyl Sulfate 是主要的尿毒症毒素,存在于慢性肾病患者的血液,来源于肝脏中酪氨酸和苯丙氨酸的代谢物。 |